Articles related to CLINICAL TRIALS

Discover how the FDA’s first draft guidance on psychedelic drugs outlines a path for future medical treatments, addressing crucial considerations from study design to safety measures. Learn more about how this pivotal step could transform the therapeutic landscape.

The results of the WU-KONG6 study offer hope for NSCLC patients with EGFR exon20 insertion mutations, demonstrating the substantial antitumor efficacy of sunvozertinib.

FIL-ROUGE trial data presented at the International Conference on Malignant Lymphoma 2023 highlight the potential of intensified ABVD in improving outcomes for untreated Hodgkin lymphoma patients. Further exploration of this regimen’s long-term toxicity is anticipated.

Explore the groundbreaking findings from the TROPiCS-02 study, revealing sacituzumab govitecan as a potential game-changer in the treatment of endocrine refractory metastatic hormone receptor-positive breast cancer.

Reconsideration of routine thromboprophylaxis in older adults may be warranted, as the SYMPTOMS trial found no significant difference in the prevention of symptomatic venous thromboembolism when comparing low-molecular-weight heparin with a placebo. Further research is needed to validate these results and determine the best strategies for VTE prevention in this demographic.

Explore the potential of technology in enhancing medication adherence among heart failure patients and the need for more robust research in this area.